UBS ASSET MANAGEMENT AMERICAS LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 107 filers reported holding THERAVANCE INC in Q2 2015. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$505,000
+13.2%
47,897
-22.9%
0.00%
Q3 2015$446,000
-33.8%
62,149
+66.6%
0.00%
-100.0%
Q2 2015$674,000
+34.5%
37,297
+16.9%
0.00%
Q1 2015$501,000
+17.3%
31,897
+5.6%
0.00%
Q4 2014$427,000
-93.7%
30,197
-92.4%
0.00%
-100.0%
Q3 2014$6,800,000
-70.4%
397,897
-48.4%
0.01%
-69.6%
Q2 2014$22,942,000
-0.9%
770,397
+2.9%
0.02%
-8.0%
Q1 2014$23,159,000
+2.1%
748,497
+17.6%
0.02%
-3.8%
Q4 2013$22,688,000
-13.3%
636,397
-0.5%
0.03%
-18.8%
Q3 2013$26,165,000
+21.4%
639,897
+14.3%
0.03%
+14.3%
Q2 2013$21,561,000559,5970.03%
Other shareholders
THERAVANCE INC shareholders Q2 2015
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders